REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 82 filers reported holding REPROS THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $970,000 | -19.9% | 1,001,000 | 0.0% | 0.21% | -8.9% |
| Q4 2015 | $1,211,000 | -85.6% | 1,001,000 | -11.6% | 0.24% | -88.7% |
| Q3 2015 | $8,413,000 | +3.9% | 1,132,367 | 0.0% | 2.08% | +11.5% |
| Q2 2015 | $8,096,000 | -16.8% | 1,132,367 | 0.0% | 1.86% | -9.2% |
| Q1 2015 | $9,727,000 | -13.8% | 1,132,367 | 0.0% | 2.05% | -48.6% |
| Q4 2014 | $11,290,000 | +0.7% | 1,132,367 | 0.0% | 4.00% | -7.7% |
| Q3 2014 | $11,210,000 | -35.4% | 1,132,367 | +12.9% | 4.33% | -26.7% |
| Q2 2014 | $17,358,000 | +74.5% | 1,003,367 | +79.0% | 5.90% | +72.4% |
| Q1 2014 | $9,945,000 | +18.3% | 560,600 | +22.0% | 3.42% | +8.7% |
| Q4 2013 | $8,409,000 | – | 459,508 | – | 3.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $8,413,000 | 2.08% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $2,445,000 | 0.72% |
| RTW INVESTMENTS, LP | 232,830 | $1,730,000 | 0.54% |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | 185,500 | $1,378,000 | 0.46% |
| GENERAL AMERICAN INVESTORS CO INC | 509,060 | $3,782,000 | 0.34% |
| Opus Point Partners Management, LLC | 98,000 | $494,000 | 0.27% |
| J. Goldman & Co LP | 350,000 | $2,601,000 | 0.22% |
| CQS Cayman LP | 240,000 | $1,783,000 | 0.15% |
| Baker Brothers Advisors | 1,955,944 | $14,533,000 | 0.13% |
| Perceptive Advisors | 440,000 | $3,270,000 | 0.13% |